Advestra advises on the placement of shares of Bachem Holding

Bachem Hold­ing suc­cess­fully placed newly issued shares rais­ing gross pro­ceeds of approx­im­ately CHF 584 mil­lion by way of an accel­er­ated book­build­ing to fin­ance invest­ments in capa­city expan­sion. Mor­gan Stan­ley and UBS were act­ing as joint glob­al coordin­at­ors and joint book­run­ners and Zürch­er Kan­ton­al­bank as joint book­run­ner in the offering.

Bachem is an innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Advestra has acted as leg­al coun­sel to the syn­dic­ate banks. The team included partner Annette Weber (pictured left), partner Thomas Reut­ter (pictured centre) and associate Valérie Bayard (pictured right; all cap­it­al markets).